Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin-dependent and tyrosine kinase-dependent manner - PubMed (original) (raw)

Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin-dependent and tyrosine kinase-dependent manner

D M Smith et al. Biochem J. 1988.

Abstract

Insulin receptor was co-purified from human placenta together with insulin-stimulated kinase activity that phosphorylates the insulin receptor on serine residues. By using this 'in vitro' system, the mechanism of activation of the serine kinase by insulin was explored. Peptide 1150, histone, poly(Glu-Tyr), eliminating Mn2+ (Mg2+ only), treatment at 37 degrees C (1 h), N-ethylmaleimide, phosphate, beta-glycerol phosphate and anti-phosphotyrosine antibody all inhibited insulin-receptor tyrosine kinase activity and the ability of insulin to stimulate phosphorylation of the insulin receptor on serine. Additionally, direct stimulation of the receptor tyrosine kinase by vanadate increased serine phosphorylation of the insulin receptor. Insulin-stimulated tyrosine phosphorylation preceded insulin-stimulated serine phosphorylation of the insulin receptor. The activity of the insulin-sensitive receptor serine kinase was not augmented by cyclic AMP, cyclic GMP, Ca2+, Ca2+ + calmodulin, Ca2+ + phosphatidylserine + diolein or spermine, or inhibited appreciably by heparin. Additionally, the serine kinase phosphorylated casein or phosvitin poorly and was active with Mn2+. This indicates that it is distinct from Ca2+, Ca2+/phospholipid, Ca2+/calmodulin, cyclic AMP- and cyclic GMP-dependent protein kinases, casein kinases I and II and insulin-activated ribosomal S6 kinase. Taken together, these data indicate that a novel species of serine kinase catalyses the insulin-dependent phosphorylation of the insulin receptor and that activation of this receptor serine kinase by insulin requires an active insulin-receptor tyrosine kinase.

PubMed Disclaimer

Cited by

Vanadium and diabetes.
Poucheret P, Verma S, Grynpas MD, McNeill JH. Poucheret P, et al. Mol Cell Biochem. 1998 Nov;188(1-2):73-80. Mol Cell Biochem. 1998. PMID: 9823013 Review.
Studies on an insulin-stimulated insulin receptor serine kinase activity: separation of the kinase activity from the insulin receptor and its reconstitution back to the insulin receptor.
Asamoah KA, Atkinson PG, Carter WG, Sale GJ. Asamoah KA, et al. Biochem J. 1995 Jun 15;308 ( Pt 3)(Pt 3):915-22. doi: 10.1042/bj3080915. Biochem J. 1995. PMID: 8948451 Free PMC article.
In vivo modulation of N-myristoyltransferase activity by orthovanadate.
King MJ, Pugazhenthi S, Khandelwal RL, Sharma RK. King MJ, et al. Mol Cell Biochem. 1995 Dec 6-20;153(1-2):151-5. doi: 10.1007/BF01075931. Mol Cell Biochem. 1995. PMID: 8927031
Activation of phosphatidylinositol 3-kinase by insulin.
Ruderman NB, Kapeller R, White MF, Cantley LC. Ruderman NB, et al. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1411-5. doi: 10.1073/pnas.87.4.1411. Proc Natl Acad Sci U S A. 1990. PMID: 2154747 Free PMC article.

References

1. Methods Enzymol. 1974;38:287-90 - PubMed
1. Diabetologia. 1981 Oct;21(4):347-62 - PubMed
1. Biochem J. 1981 Jun 1;195(3):653-60 - PubMed
1. Nature. 1982 Aug 12;298(5875):667-9 - PubMed
1. Biochem J. 1982 Aug 15;206(2):221-9 - PubMed

Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin-dependent and tyrosine kinase-dependent manner - PubMed (original) (raw)